HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

S Kuriyama Selected Research

Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)

12/2005Angiopoietin 2 displays a vascular endothelial growth factor dependent synergistic effect in hepatocellular carcinoma development in mice.
9/2003Vascular endothelial growth factor and receptor interaction is a prerequisite for murine hepatic fibrogenesis.
4/2001The vascular endothelial growth factor receptor KDR/Flk-1 is a major regulator of malignant ascites formation in the mouse hepatocellular carcinoma model.
4/2001The angiotensin-I-converting enzyme inhibitor perindopril suppresses tumor growth and angiogenesis: possible role of the vascular endothelial growth factor.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


S Kuriyama Research Topics

Disease

12Neoplasms (Cancer)
02/2016 - 01/2000
9Hepatocellular Carcinoma (Hepatoma)
12/2005 - 07/2000
6Liver Cirrhosis (Hepatic Cirrhosis)
09/2003 - 10/2000
3Lung Neoplasms (Lung Cancer)
02/2016 - 07/2003
3Colorectal Neoplasms (Colorectal Cancer)
09/2004 - 01/2000
3Fibrosis (Cirrhosis)
09/2003 - 12/2000
3Carcinoma (Carcinomatosis)
02/2003 - 09/2002
2Crohn Disease (Crohn's Disease)
06/2009 - 11/2006
2Retinal Detachment (Retinal Detachments)
09/2008 - 05/2000
2Liver Diseases (Liver Disease)
10/2003 - 12/2000
2Adenoma (Adenomas)
09/2002 - 01/2001
2Hypertension (High Blood Pressure)
09/2001 - 09/2000
2Anemia
09/2001 - 09/2000
2Ascites
04/2001 - 08/2000
1Osteoarthritis
03/2019
1Lipoma (Lipomata)
02/2016
1Adenocarcinoma of Lung
02/2016
1Insulin Resistance
06/2009
1Hemorrhage
09/2008
1Retinal Perforations
09/2008
1Stomach Ulcer (Gastric Ulcer)
02/2007
1Prostatic Neoplasms (Prostate Cancer)
08/2006
1Water Intoxication
07/2006
1Colonic Neoplasms (Colon Cancer)
09/2004
1Constipation
09/2004
1Multiple System Atrophy
01/2004
1Adenocarcinoma
07/2003
1Fistula
01/2003
1Pleural Effusion (Pleural Effusions)
01/2003
1Necrosis
10/2002
1Neoplasm Metastasis (Metastasis)
09/2002
1Polyps
09/2002
1IGA Glomerulonephritis (IGA Nephropathy)
05/2002
1Hepatolenticular Degeneration (Wilson's Disease)
12/2001
1Osteomyelitis
11/2001
1Lacerations
11/2001
1Fracture Dislocation
11/2001
1Autoimmune Hepatitis
08/2001
1Chronic Hepatitis (Chronic Active Hepatitis)
08/2001
1Biliary Liver Cirrhosis (Primary Biliary Cirrhosis)
06/2001
1Portal Hypertension
06/2001

Drug/Important Bio-Agent (IBA)

4Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
12/2005 - 04/2001
3Hydroxyproline (4 Hydroxyproline)IBA
09/2003 - 12/2000
3Messenger RNA (mRNA)IBA
09/2003 - 10/2001
3Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA
10/2001 - 12/2000
3Bleomycin (Blenoxane)FDA LinkGeneric
03/2001 - 01/2000
2TeaIBA
10/2008 - 08/2006
2Angiogenesis Inducing Agents (Angiogenesis Factor)IBA
09/2003 - 04/2001
2Phosphotransferases (Kinase)IBA
07/2003 - 12/2002
2Cyclin EIBA
12/2002 - 09/2002
2Ethanol (Ethyl Alcohol)IBA
10/2002 - 01/2001
2Angiotensin Receptor AntagonistsIBA
05/2002 - 12/2000
2Type 1 Angiotensin ReceptorIBA
10/2001 - 04/2001
2Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA
10/2001 - 04/2001
2PerindoprilFDA LinkGeneric
10/2001 - 04/2001
2ErythropoietinFDA Link
09/2001 - 09/2000
2Neutralizing AntibodiesIBA
04/2001 - 03/2000
2alpha-Fetoproteins (alpha-Fetoprotein)IBA
01/2001 - 07/2000
2Thymidine KinaseIBA
01/2001 - 08/2000
1Cadherins (E-Cadherin)IBA
02/2016
1CollagenIBA
02/2016
1Matrix Metalloproteinase 15IBA
02/2016
1Microfilament Proteins (Actin Binding Proteins)IBA
02/2016
1Small Leucine-Rich ProteoglycansIBA
01/2015
1Insulin (Novolin)FDA Link
06/2009
1EnbucrilateIBA
02/2007
1Icodextrin (Extraneal)FDA Link
07/2006
1Angiopoietin-2IBA
12/2005
1LaxativesIBA
09/2004
1Vasopressins (Vasopressin)IBA
01/2004
1Thyroxine (Levothyroxine)FDA LinkGeneric
10/2003
1Vascular Endothelial Growth Factor Receptor-1 (fms-Like Tyrosine Kinase)IBA
09/2003
1Monoclonal AntibodiesIBA
09/2003
1Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)IBA
09/2003
1Protein-Tyrosine Kinases (Tyrosine Kinase)IBA
07/2003
1PhosphopeptidesIBA
07/2003
1Telomerase (Telomerase Reverse Transcriptase)IBA
02/2003
1Somatostatin (Somatotropin Release-Inhibiting Factor)IBA
01/2003
1Cyclin AIBA
09/2002
1Calcium Channel Blockers (Blockers, Calcium Channel)IBA
05/2002
1Trientine (Trien)FDA Link
12/2001
1Chelating AgentsIBA
12/2001
1Drinking WaterIBA
12/2001
1Penicillamine (Cuprimine)FDA Link
12/2001
1CopperIBA
12/2001
1candesartanIBA
10/2001
1AngiotensinogenIBA
09/2001
1Codon (Codons)IBA
09/2001
1Keratins (Keratin)IBA
08/2001
1AntibodiesIBA
08/2001
1Endothelin-1 (Endothelin 1)IBA
06/2001

Therapy/Procedure

8Therapeutics
06/2009 - 12/2000
2Vitrectomy
09/2008 - 05/2000
1Knee Replacement Arthroplasty (Total Knee Replacement)
03/2019
1Cannula
09/2008
1Sclerotherapy
02/2007
1Peritoneal Dialysis
07/2006
1Radiofrequency Ablation
10/2002
1Laparotomy
11/2001
1Colostomy
11/2001